Browsing Tag
Kidney transplant
5 posts
How Hansa Biopharma’s imlifidase could redefine access for hardest-to-match transplant candidates
Hansa Biopharma seeks FDA approval for imlifidase to expand transplant eligibility in high-risk ESRD patients. See what this filing means for U.S. access.
December 22, 2025
CASI Pharmaceuticals advances in kidney transplant treatment and explores strategic sale in China
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a notable player in the biopharmaceutical sector, has made a significant announcement that…
June 27, 2024
Zydus Lifesciences gets FDA final approval for Rapamune generic – Sirolimus Tablets
Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) for Sirolimus Tablets, 1…
February 17, 2023
Memo Therapeutics secures $15.5m in Series B to propel antibody development for COVID-19 and BK virus treatment
Memo Therapeutics, a Swiss biotech company, has successfully raised CHF 14 million (approximately $15.56 million) in a Series…
November 8, 2020
Talaris initiates FREEDOM-1 clinical trial for FCR001 in LDKT recipients
Talaris Therapeutics has initiated the phase 3 FREEDOM-1 clinical trial to evaluate its investigational, allogeneic cell therapy FCR001…
October 24, 2019